The Adipose Tissue Derived Stem Cell Therapy Market is gaining momentum as regenerative medicine advances toward cell-based approaches for tissue repair, wound healing, and treatment of degenerative conditions. The market size is expected to reach US$ 31.61 Billion by 2034, up from US$ 15.3 Billion in 2025, registering a CAGR of 8.39% from 2026 to 2034. Increasing research activity, expanding clinical applications, and improvements in cell processing technologies are creating new opportunities for therapy developers and healthcare stakeholders.

There has been considerable debate over personal lifestyles changes as a political means to achieve society-wide decarbonization.

PDF | Money is conventionally understood to depreciate when its purchasing power declines, its exchange value falls, or inflation reduces the quantity... | Find, read and cite all the research you nee...

Sen.

Mossy Rock Cattle Company sees regenerative agriculture as an answer to their long-term viability. They’re not the only Indigenous farm to think so.

Mossy Rock Cattle Company sees regenerative agriculture as an answer to their long-term viability. They’re not the only Indigenous farm to think so.

What happens when a medical treatment is no longer a standardised product, but is created for an individual patient — using living cells, biomaterials and a 3D printer, directly in the operating room?...

According to The Insight Partners, Automated Cell Culture Market size is expected to reach US$ 534.86 Million by 2034 from US$ 271.95 Million in 2025. The market is anticipated to register a CAGR of 7.81% during the forecast period 2026–2034. The Automated Cell Culture Market is witnessing significant growth as the life sciences, biopharmaceutical, and regenerative medicine sectors increasingly adopt automation to enhance laboratory efficiency, reproducibility, and scalability.

The Bio Implants Market is moving toward a more advanced phase of medical-device innovation as healthcare providers increasingly look for implantable solutions that can work more naturally with the human body. Advances in biomaterials, regenerative medicine, implant design, and surgical technologies are creating new possibilities across orthopedic, dental, cardiovascular, auditory, and other clinical applications. The Bio Implants Market size is expected to reach…

The 3D Bioprinting Market was valued at US$ 2.00 Billion in 2025 and is projected to reach US$ 4.92 Billion by 2034, registering a CAGR of 13.7% during 2026–2034. 3D bioprinting combines additive manufacturing with biomaterials, cells, and bioactive components to create tissue-like structures for research, drug development, regenerative medicine, and other biomedical applications. Increasing investment in tissue engineering, advances in biomaterials and printing technologies, growing demand for advanced drug-testing models, and expanding research into regenerative medicine are supporting market growth.

1 October 2026 (Navroze Bureau)  Researchers at the Indian Institute of Technology Hyderabad have developed a novel bioink designed to closely reproduce the biological and mechanical environment of lung tissue, potentially opening new possibilities for lung tissue engineering, regenerative medicine, disease modelling and drug testing. The research focuses on a major challenge in 3D bioprinting: creating artificial tissue that does not merely resemble the physical structure of an organ but also provides the biological signals needed to guide cells and regulate immune responses.